BioWorld

Oct. 4, 1991

View Archived Issues

TRIALS BEGIN ON VIMRX AIDS DRUG

Read More

MID-ATLANTIC VENTURE FAIR HIGHLIGHTS

Read More

ONCOSCINT APPROVED IN GERMANY

Read More

MIXED SIGNALS ON CENTOXIN PROSPECTS

Read More

DNAP RAISES $28.4 MILLION IN STOCK SALE

Read More

CLUE TO AIDS VACCINE EFFECTIVENESS

Read More

SYNERGEN TO SPLIT STOCK 3 FOR 2

Read More

NEW COMPANY TO FOCUS ON CELL RECEPTORS

Read More